Notice of Intent to Sole Source 10x Genomics, Inc.

PresolicitationActive

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in BETHESDA, MD
  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Contract Details

Notice ID
NOI-OD-26-007025
Opportunity Type
Presolicitation
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Posted Date
Friday, July 24, 2026
Response Deadline
Not specified
PSC Code
6550
Set-Aside
Full & Open Competition
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a firm fixed priced contract to 10X Genomics Inc. for the acquisition of reagents and consumables required for the Early Detection of Lung Diseases (EDLI) project. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the c

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in BETHESDA, MD.